Immunovant, Inc.IMVTNASDAQ
LOADING
|||
| Metric | Mar 21 | Mar 22 | Mar 23 | Mar 24 | Mar 25 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -108 | -156↓44.3% | -208↓33.5% | -270↓29.7% | -438↓62.2% |
| Net Income | -107 | -157↓45.9% | -211↓34.6% | -259↓22.9% | -414↓59.6% |
| EBITDA | -108 | -156↓44.3% | -208↓33.5% | -270↓29.7% | -438↓62.2% |
| EPS Diluted | -1.22 | -1.43↓17.2% | -1.71↓19.6% | -1.88↓9.9% | -2.73↓45.2% |